Jane Anne Leopold MD
Interventional Cardiology
Associate Professor of Medicine, Brigham and Women's Hospital
Join to View Full Profile
75 Francis StreetBrigham & Womens HospitalBoston, MA 02115
Phone+1 617-732-5500
Fax+1 617-525-4830
Dr. Leopold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterFellowship, Cardiovascular Disease, 1994 - 1998
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
Boston University School of MedicineClass of 1991
Certifications & Licensure
MA State Medical License 1993 - 2026
RI State Medical License 2018 - 2020
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- My Research Legacy Pilot Study Start of enrollment: 2016 Nov 11
Publications & Presentations
PubMed
- Echocardiographic Parameters Enhance Risk Prediction Scores in Pulmonary Arterial Hypertension: Insights from the PVDOMICS Network.Monica Mukherjee, Vivek P Jani, Ryan Osgueritchian, Hoda Mombeini, Aiden Abidov
Chest. 2025-04-11 - Physical Activity, Sleep, and Quality of Life in Pulmonary Arterial Hypertension: Novel Insights From Wearable Devices.Andrew M Hughes, Alisha Lindsey, Jeffrey Annis, Kelly Burke, Hiral Master
Pulmonary Circulation. 2025-04-01 - Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective.Nkiru Osude, Harriette Van Spall, Hayden Bosworth, Konstantin Krychtiuk, John Spertus
American Heart Journal. 2025-03-17
Press Mentions
$1M Awarded to Research Link Between Cardiovascular Risk Reduction, GLP-1 UseApril 29th, 2025- American Heart Association Awards $1M for GLP-1 Medication Cardiovascular ResearchApril 29th, 2025
- Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-Class Medication Shows Promise in Treating Rare Heart Lung ConditionMarch 6th, 2023
- Join now to see all
Grant Support
- Aldosterone, Autophagy, And Arterial StiffnessNational Heart, Lung, And Blood Institute2010–2011
- Sickle Cell Disease G6PDNational Heart, Lung, And Blood Institute2008–2011
- Aldosterone, G6pd, And Vascular Endothelial FunctionNational Heart, Lung, And Blood Institute2005–2009
- G6PD And Oxidant Stress In Vascular Smooth Muscle CellsNational Heart, Lung, And Blood Institute2000–2004
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
